LOGLIO, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 1.148
NA - Nord America 1.134
AS - Asia 1.099
SA - Sud America 154
AF - Africa 20
OC - Oceania 7
Totale 3.562
Nazione #
US - Stati Uniti d'America 1.109
CN - Cina 432
GB - Regno Unito 412
SG - Singapore 393
IT - Italia 180
DE - Germania 154
BR - Brasile 126
HK - Hong Kong 98
SE - Svezia 89
RU - Federazione Russa 78
IN - India 50
FR - Francia 48
NL - Olanda 45
DK - Danimarca 35
IE - Irlanda 35
VN - Vietnam 27
TR - Turchia 20
CA - Canada 18
ID - Indonesia 17
FI - Finlandia 14
JP - Giappone 14
BE - Belgio 13
AR - Argentina 12
CI - Costa d'Avorio 11
AT - Austria 8
PL - Polonia 8
UA - Ucraina 7
AU - Australia 6
ES - Italia 6
IQ - Iraq 6
KR - Corea 6
TW - Taiwan 5
UZ - Uzbekistan 5
BD - Bangladesh 4
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
MY - Malesia 4
VE - Venezuela 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
MX - Messico 3
CZ - Repubblica Ceca 2
EC - Ecuador 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
LV - Lettonia 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.562
Città #
Southend 386
Singapore 239
Chandler 189
Ashburn 185
Milan 113
Beijing 89
Hong Kong 89
Frankfurt am Main 76
Dallas 61
Ann Arbor 46
Princeton 42
Council Bluffs 36
Fairfield 36
Dublin 35
San Jose 34
Wilmington 29
Los Angeles 26
Bengaluru 24
Dearborn 22
Grafing 22
Hefei 21
Boardman 20
Buffalo 20
Des Moines 20
Houston 20
Santa Clara 19
Moscow 16
Piscataway 16
Columbus 15
Guangzhou 15
Nanjing 15
Woodbridge 15
São Paulo 14
The Dalles 14
Brussels 13
Hangzhou 13
Istanbul 13
Tokyo 13
New York 12
Seattle 12
Abidjan 11
Cangzhou 10
Fremont 10
Hanoi 10
Redwood City 10
Toronto 10
Berlin 8
Helsinki 8
Gorla Maggiore 7
Jakarta 7
Shanghai 7
Tianjin 7
Brooklyn 6
Changsha 6
Fuzhou 6
Nanchang 6
Roubaix 6
Central District 5
Cinisello Balsamo 5
Ho Chi Minh City 5
Jiaxing 5
Jinan 5
Munich 5
New Taipei City 5
Nuremberg 5
Phoenix 5
San Francisco 5
Seoul 5
Shenyang 5
Vienna 5
Zhengzhou 5
Belo Horizonte 4
Dong Ket 4
Düsseldorf 4
Hebei 4
Lappeenranta 4
Rio de Janeiro 4
Warsaw 4
Wroclaw 4
Baghdad 3
Bexley 3
Buenos Aires 3
Bühl 3
Cambridge 3
Caxias do Sul 3
Clifton 3
Groningen 3
Kunming 3
Ladispoli 3
Ottawa 3
Recife 3
Shenzhen 3
Stockholm 3
Tappahannock 3
Turin 3
Washington 3
Wuhan 3
Amsterdam 2
Ankara 2
Bogotá 2
Totale 2.392
Nome #
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma 215
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices : a 12-year prospective cohort study 211
The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy 194
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance 188
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies : two case reports 185
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis : a case report of 3 patients 172
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir 172
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients 171
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy 171
Circulating cell-free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients 162
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients 160
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B 159
Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs) 139
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B 135
Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide 126
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population 120
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B 116
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis 114
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B 112
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 108
How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals? 107
Hepatitis D–how is the fight against this foe going? 103
Treatment of hepatitis B : is there still a role for interferon? 101
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension 84
Changes in bone mineral density during monotherapy with tenofovir disoproxil fumarate: a 6-year real life longitudinal cohort study in chronic hepatitis B caucasian patients 79
Incidence and Predictors of Complications Following Percutaneous Liver Biopsy: A Large Italian Multicentre Study. 74
Novel Therapies That May Cure Chronic Hepatitis B Virus. 48
null 9
Totale 3.735
Categoria #
all - tutte 11.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 14 18 66 53 11 71
2021/2022319 22 15 26 12 16 11 12 17 18 52 19 99
2022/2023429 54 67 57 52 37 82 3 20 26 6 12 13
2023/2024295 8 21 3 22 60 10 46 21 20 9 35 40
2024/2025833 38 73 14 88 53 32 41 69 33 116 80 196
2025/2026925 206 106 187 131 149 114 32 0 0 0 0 0
Totale 3.735